Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium channel protein type 3 subunit alpha
- Molecular classification
- Ion channel, Voltage-gated sodium channel
01
Overview
The sodium channel protein type 3 subunit alpha (Nav1.3), encoded by the SCN3A gene, is a pore-forming subunit of the voltage-gated sodium channel. It mediates the depolarizing phase of action potentials in excitable membranes. Mutations or dysfunctions are associated with various neurological conditions including epilepsy.
- Other names
- Nav1.3SCN3A
02
Mechanism of action
Voltage-gated sodium channel blockade
03
Biological functions
Membrane depolarizationAction potential generationNeuronal excitability
04
Disease associations
EpilepsyNeurodevelopmental disorders
Beyond the preview
Go deeper on Sodium channel protein type 3 subunit alpha.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sodium channel protein type 3 subunit alpha.